Bell Investment Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $385 | Sell |
7
-31
| -82% | -$1.71K | ﹤0.01% | 1811 |
|
|
2025
Q1 | $2.69K | Buy |
38
+15
| +65% | +$1.06K | ﹤0.01% | 1188 |
|
|
2024
Q4 | $1.51K | Buy |
23
+10
| +77% | +$657 | ﹤0.01% | 1434 |
|
|
2024
Q3 | $914 | Sell |
13
-19
| -59% | -$1.34K | ﹤0.01% | 1621 |
|
|
2024
Q2 | $2.64K | Buy |
32
+5
| +19% | +$412 | ﹤0.01% | 1243 |
|
|
2024
Q1 | $2.36K | Buy |
27
+6
| +29% | +$524 | ﹤0.01% | 1282 |
|
|
2023
Q4 | $2.03K | Sell |
21
-16
| -43% | -$1.54K | ﹤0.01% | 1318 |
|
|
2023
Q3 | $3.27K | Buy |
37
+16
| +76% | +$1.42K | ﹤0.01% | 1030 |
|
|
2023
Q2 | $1.82K | Buy |
21
+6
| +40% | +$520 | ﹤0.01% | 1346 |
|
|
2023
Q1 | $1.46K | Sell |
15
-15
| -50% | -$1.46K | ﹤0.01% | 1410 |
|
|
2022
Q4 | $3.11K | Sell |
30
-3
| -9% | -$311 | ﹤0.01% | 1051 |
|
|
2022
Q3 | $3K | Hold |
33
| – | – | ﹤0.01% | 880 |
|
|
2022
Q2 | $3K | Buy |
+33
| New | +$3K | ﹤0.01% | 899 |
|
|
2021
Q4 | $4K | Buy |
40
+2
| +5% | +$200 | ﹤0.01% | 835 |
|
|
2021
Q3 | $3K | Buy |
+38
| New | +$3K | ﹤0.01% | 884 |
|